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Accepted 25 October 2011AbstractObjective: To present prenatal diagnosis of true trisomy 7 mosaicism.
Materials, Methods and Results: A 36-year-old woman underwent amniocentesis at 18 weeks of gestation. Amniocentesis revealed a karyotype
of 47,XY,þ7[20]/46,XY[9]. The parental karyotypes were normal. Repeated amniocentesis was performed at 20 weeks of gestation. Array
comparative genomic hybridization (aCGH) analysis on uncultured amniocytes manifested a genomic gain in chromosome 7. Quantitative
fluorescent polymerase chain reaction (QF-PCR) analysis on uncultured amniocytes showed a biparental diallelic pattern with a dosage increase
in the maternal allele. Interphase fluorescence in situ hybridization (FISH) on uncultured amniocytes revealed three 7q-specific signals in 13 of
50 (26%) of the cells. The cultured amniocytes had a karyotype of 47,XY,þ7[12]/46,XY[14]. The ultrasound findings were unremarkable. The
pregnancy was subsequently terminated, and a fetus was delivered with facial dysmorphisms. Postnatal tissue samplings revealed the mosaic
trisomy 7 level of 37.5% (15/40), 30% (12/40), 42.5% (17/40), 82.5% (33/40), 52.5% (21/40), and 27.5% (11/40) in skin, liver, lungs, placenta,
membrane, and cord, respectively. The cord blood had a karyotype of 46,XY. PEG1/MEST methylation-sensitive high-resolution melting PCR
assay of cord blood showed no uniparental disomy for chromosome 7.
Conclusion: Interphase FISH, QF-PCR, and aCGH analyses on uncultured amniocytes are useful for rapid distinguishing of true mosaicism from
pseudomosaicism for trisomy 7 at amniocentesis. Cord blood sampling for confirmation of fetal trisomy 7 mosaicism is not practical.
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Genetic counseling of mosaic trisomy at amniocentesis
is difficult because of the phenotypic variability associated
with the condition with some fetuses exhibiting the typicalcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Trisomy 7 mosaicism may present variable and non-specific
clinical features ranging from normal to facial dysmorphisms,
enamel dysplasia, sparse hair, hypomelanosis of Ito, pigmentary
abnormalities, radial defects, Potter syndrome, Goldenhar
syndrome, and Blaschkolinear malformation syndrome [2e8].
Trisomy 7 mosaicism at amniocentesis has been reported to be
associated with a normal karyotype in the lymphocytes of the
cord blood and peripheral blood [9]. Maternal uniparental
disomy for chromosome 7 (UPD 7) may be observed in cases
of trisomy 7 mosaicism with Silver-Russell syndrome (SRS)
[10e13]. Here, we report prenatal diagnosis of trisomy 7
mosaicism by amniocentesis using cultured and uncultured
amniocytes in the second trimester. We demonstrate the
application of molecular cytogenetic technologies in uncul-
tured amniocytes for rapid confirmation of fetal mosaicism,
searching for UPD, and distinguishing true mosaicism from
pseudomosaicism.
Methods and results
A 36-year-old, gravid 3, para 1 woman underwent amnio-
centesis at 18 weeks of gestation at a local hospital because of
advanced maternal age. There was no family history of
congenital malformations. Her husband was 39 years old, and
the couple had a 3-year-old healthy child. In 20 of 29 sepa-
rated cultured amniocyte colonies, an abnormal karyotype of
47,XY,þ7 was found (Fig. 1), while the other nine colonies
had a karyotype of 46,XY. The cytogenetic result ofFig. 1. A karyotypeamniocentesis was 47,XY,þ7[20]/46,XY[9]. She was referred
to the hospital at 19 weeks of gestation for genetic counseling
and repeated amniocentesis. The parental karyotypes were
normal. The fetal ultrasound findings were unremarkable.
Molecular cytogenetic techniques such as array comparative
genomic hybridization (aCGH), interphase fluorescence in situ
hybridization (FISH), and quantitative fluorescent polymerase
chain reaction (QF-PCR) were applied to the uncultured
amniocytes. The aCGH investigation using CytoChip Oligo
array (BlueGnome, Cambridge, UK) on uncultured amniocytes
manifested a genomic gain in chromosome 7 (Fig. 2). Poly-
morphic DNA marker analysis of the amniotic fluid sample
with uncultured amniocytes using QF-PCR and microsatellite
markers specific for chromosome 7 revealed a biparental dia-
llelic pattern. The uncultured amniotic fluid sample had
unequal biparental inheritance of chromosome 7 with a dosage
increase in the maternal allele (Fig. 3). Interphase FISH anal-
ysis on uncultured amniocytes using a 7q11.1-specific probe
(RP11-432A1) showed three 7q-sepcific signals in 13/50 (26%)
of uncultured amniocytes and two signals in 37/50 (74%) of
uncultured amniocytes (Fig. 4). The molecular cytogenetic
results were consistent with true mosaicism, and UPD 7 was
excluded. Cytogenetic analysis of cultured amniocytes at
repeated amniocentesis revealed a karyotype of 47,XY,þ7[12]/
46,XY[14]. The parents decided to terminate the pregnancy. A
426-g male fetus was delivered with facial asymmetry, low-set
ears, long philtrum, and hypertelorism. Cytogenetic analysis of
the cord blood revealed a karyotype of 46,XY in 40/40
of lymphocytes. Fetal and extraembryonic tissue samplingsof 47,XY,þ7.
Fig. 2. Oligonucleotide-based array comparative genomic hybridization (aCGH) analysis using CytoChip Oligo array on uncultured amniocytes shows a genomic
gain in chromosome 7.
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a karyotype of 47,XY, þ7[12]/46,XY[28] in the liver, a karyo-
type of 47,XY,þ7[17]/46,XY[23] in the lungs, a karyotype of
47,XY,þ7[11]/46,XY[29] in the umbilical cord, a karyotype
of 47,XY,þ7[21]/46,XY[19] in the amniotic membrane, and
a karyotype of 47,XY,þ7[33]/46,XY[7] in the placenta. A
PEG1/MEST methylation-sensitive high-resolution melting
PCR assay was performed to identify the differential methyla-
tion of the imprinted PEG1/MEST locus on 7q32 in the cordblood. The result revealed biparental inheritance of chromo-
some 7 in the cord blood (Fig. 5).
Discussion
The present case was associated with true mosaic trisomy
7 and dysmorphisms. Mosaic trisomy 7 at amniocentesis has
been associated with pseudomosaicism [14]. We previously
observed discrepancy between the cytogenetic results of
Fig. 3. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction (QF-PCR) assays at short tandem repeat markers
specific for chromosome 7 in the amniotic fluid sample with uncultured
amniocytes. The marker D7S794 (7q34) shows two peaks (166 bp: 170 bp;
maternal allele: paternal allele) from two different parental alleles and
a dosage increase in the maternal allele.
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amniocytes in mosaic trisomy 7 at amniocentesis [9]. In the
present case, the first amniocentesis revealed 69% (20/29)
mosaicism for trisomy 7 in cultured amniocytes, and the second
amniocentesis revealed 46.2% (12/26) mosaicism for trisomy 7
in cultured amniocytes. However, the interphase FISH resultFig. 4. Interphase fluorescence in situ hybridization (FISH) analysis on uncultured a
spectrum green) shows (A) three green signals in an abnormal cell with trisomy 7revealed only 26% (13/50) mosaicism for trisomy 7. This result
provides evidence that a high level of trisomy 7 in cultured
amniocytes might be derived from a cell culture effect from
a low level of trisomy 7 mosaicism in uncultured amniocytes.
In this presentation, both QF-PCR and aCGH were able to
detect 26% mosaicism for trisomy 7 in uncultured amniocytes.
QF-PCR assay has been reported to detect mosaicism as low
as 15% of the whole sample [15]. aCGH has been reported to
detect mosaicism as low as 20% in the peripheral blood
samples [16,17] or even the level of 10% in prenatal diagnosis
[18]. However, the detection rate of mosaic trisomy using
aCGH on uncultured amniocytes is variable according to
different products of array chips. For example, we previously
failed to detect mosaicism in uncultured amniocytes in a case
with 25% (5/20) mosaicism for trisomy 8 by aCGH using
CMDX Oligo HD Scan array [19]. In another study, we failed
to detect mosaicism in uncultured amniocytes in a case with
18% (9/50) mosaicism for trisomy 9 by aCGH using CMDX
BAC aCGH chips [20]. However, we were able to detect
mosaicism in uncultured amniocytes in two separate cases
with 48% (12/25) mosaicism for trisomy 9 and 12% (6/50)
mosaicism for trisomy 2, respectively, by aCGH using Cyto-
Chip Oligo array [21,22].
The present case provides evidence for cytogenetic
discrepancy between cord blood and other fetal and extra-
embryonic tissues in prenatally detected mosaic trisomy 7. It is
obvious that cord blood sampling for confirmation of mosaic
trisomy 7 at amniocentesis is not useful. In this study, cyto-
genetic analyses of the fetal tissues including skin, liver, and
lungs revealed mosaic trisomy 7 in the mosaic levels of 37.5%
(15/40), 30% (12/40), and 42.5% (17/40), respectively; and
cytogenetic analyses of the extraembryonic tissues including
placenta, membrane, and cord revealed mosaic trisomy 7 in
the mosaic level of 82.5% (33/40), 52.5% (21/40), and 27.5%
(11/40), respectively. However, the cord blood presented
a normal karyotype in 40/40 cells examined. Our observation
is in accordance with previous reports that most patients with
trisomy 7 mosaicism have a normal karyotype in blood
lymphocytes [5,8e12,23].mniocytes using a bacterial artificial chromosome probe RP11-432A1 (7q11.1;
and (B) two green signals in a normal cell with disomy 7.
Fig. 5. PEG1/MEST methylation-sensitive high-resolution melting polymerase chain reaction (PCR) assay shows (A) a normal wild type with unmethylated and
methylated alleles, (B) a positive control of maternal uniparental disomy for chromosome 7 with only the methylated maternal allele, and (C) the cord blood of the
fetus with unmethylated and methylated alleles.
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should alert intrauterine growth restriction, UPD 7, and SRS
[10e13]. Prenatal diagnosis of UPD 7 can be rapidly made
either by QF-PCR assays by means of genotyping the fetus and
the parents with microsatellite markers to identify the loss of
one parental contribution, or by methylation-specific PCR by
means of differential methylation of the imprinted PEG1/
MEST locus on 7q32. Because cord blood usually has a normal
karyotype in cases with mosaic trisomy 7, it is a useful source
for perinatal identification of maternal UPD 7.
In conclusion, interphase FISH, QF-PCR, and aCGH
analyses on uncultured amniocytes are useful for rapid dis-
tinguishing of true mosaicism from pseudomosaicism for
trisomy 7 at amniocentesis. Cord blood sampling for confir-
mation of fetal trisomy 7 mosaicism is not practical.Acknowledgments
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